OLR1 and Myocardial fibrosis: In conclusion, we demonstrate for the first time that LOX-1 is an important player in aging-induced cardiac fibrosis, and LOX-1 deletion has the potential to attenuate myocardial fibrosis and inhibit ROS production in the hearts of aging mice.